Presseportal.de - SEGRAMhttps://www.presseportal.de/st/SEGRAM?langid=2Presseportal - Deutschlands umfassende Datenbank für Presseinformationen in Text, Bild, Ton und Video - ein Service der dpa-Tochter news aktuellde-denews aktuell GmbHhttps://www.presseportal.de/images/logos/logo-de-250.jpgPresseportal.de - SEGRAMhttps://www.presseportal.de/st/SEGRAM?langid=2info@presseportal.de (presseportal.de)Thu, 09 Jul 2026 02:54:54 +0200Wed, 08 Jul 2026 09:56:29 +0200SEGRAM6Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular DystrophyGrünenthal Group: Aachen (ots) - Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular ...https://www.presseportal.de/pm/118252/6310386?langid=2Wed, 08 Jul 2026 09:56:29 +0200https://www.presseportal.de/pm/118252/6310386?langid=2 Grünenthal Group [Newsroom]
Aachen (ots) - Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular ... Lesen Sie hier weiter...

Original-Content von: Grünenthal Group, übermittelt durch news aktuell

]]>Gesundheit / Medizininfo@presseportal.de (presseportal.de)Grünenthal Group